RxDoctor Payments Data

Tzvi Nussbaum, MD

Vascular Surgery · Charlotte, NCNPI 1205938255

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $14,027 of the $15,924 with a category attached, or 88.1%. 17 manufacturers reported payments, led by Medtronic at 49.8% of the total. Reporting peaked in 2019 at $4,783 and has fallen 86.4% since, to $649 in 2025.

$15,924in general payments, 2019–2025

Across 269 payments — averaging $59.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Bard Peripheral Vascular, Inc.$2K
  • Philips North America LLC$968
  • W. L. Gore & Associates, Inc.$903
  • Silk Road Medical, Inc.$819
  • Cook Medical LLC$742
  • plus $3K from 11 others
$5,235in research payments, 2019–2025

Across 1 payment — averaging $5235.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Phraxis, Inc.$5K

What the payments were for

  • Travel & lodging$1,89712%
  • Food & beverage$14,02788%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,924 in reported general payments places this provider in the 80th percentile of 119 vascular surgery providers in North Carolina.

See all vascular surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$158,814
Medicare patients
359
Services billed
797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$42,230
XareltoRivaroxaban49$31,214
Cilostazol36$523
ClopidogrelClopidogrel Bisulfate40$340
Gabapentin13$34

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →